{
    "clinical_study": {
        "@rank": "3100", 
        "arm_group": [
            {
                "arm_group_label": "Dietary Supplement capsule", 
                "arm_group_type": "Active Comparator", 
                "description": "One capsule at meals (3 each day) during 1 year with Omega-3 fatty acid supplementation"
            }, 
            {
                "arm_group_label": "Empty gelatine capsule", 
                "arm_group_type": "Placebo Comparator", 
                "description": "One capsule at meals (3 each day during 1 year)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether an omega-3 fatty acid supplementation is\n      effective in the prevention of progressive cognitive decline in elderly people aged 75 years\n      or older."
        }, 
        "brief_title": "Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Mild Cognitive Impairment", 
        "condition_browse": {
            "mesh_term": "Cognition Disorders"
        }, 
        "detailed_description": {
            "textblock": "Participants are residents at three nursing homes in Pamplona (Spain). We assumed that 20%\n      of elderly people have a cognitive decline and we estimated a 5% of cognitive decline in the\n      intervention group. Sample size estimated was 85 participants for each arm, assuming two\n      groups with an alpha of 0.05, 80% power and accounting for 10% of participants lost to\n      follow-up.\n\n      Repeated measures ANOVA, Cox regression and multiple linear regression analysis will be used\n      for the statistical analysis of data."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Elderly people aged 75 years or older\n\n          -  Global Deterioration Scale < 4\n\n          -  Capacity to complete the tests\n\n        Exclusion Criteria:\n\n          -  Neurological, physical or psychiatry conditions, obtained from the medical history,\n             that may have an influence on the cognitive function.\n\n          -  Dementia\n\n          -  History of epilepsy, convulsions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "75 Years"
        }, 
        "enrollment": {
            "#text": "170", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01817101", 
            "org_study_id": "DIET"
        }, 
        "intervention": {
            "arm_group_label": "Dietary Supplement capsule", 
            "description": "Gelatine capsule, 1 at each meals (3 per day) during one year", 
            "intervention_name": "Omega-3 fatty acid supplementation", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 20, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Maria Pardo", 
                    "phone": "0034948153866"
                }, 
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra"
                    }, 
                    "name": "Amma Argaray"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Belen Illarregui", 
                    "phone": "0034948382626"
                }, 
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra"
                    }, 
                    "name": "AMMA Oblatas"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jose Ignacio Gost", 
                    "phone": "0034948291606"
                }, 
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra"
                    }, 
                    "name": "AMMA Mutilva"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population", 
        "overall_contact": {
            "email": "jbaleztena@unav.es", 
            "last_name": "Joaquin Baleztena, MD", 
            "phone": "+34948255400", 
            "phone_ext": "3237"
        }, 
        "overall_official": {
            "affiliation": "Clinica Universidad de Navarra", 
            "last_name": "Joaquin Baleztena, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "MMSE is a brief questionnaire test that is used to screen for cognitive impairment. A validated test in Spanish will be used:\nLobo A. Saza P. Marcos G, D\u00edaz J, De la C\u00e1mara C, Ventura T et al: Revalidaci\u00f3n y normalizaci\u00f3n del Mini-Examen Cogniscitivo (primera versi\u00f3n en castellano del Mini-Mental Status Examination) en la poblaci\u00f3n general geri\u00e1trica. Med Clin (Barc) 1999;112:767-774.", 
            "measure": "Mini Mental State Examination", 
            "safety_issue": "No", 
            "time_frame": "Six months / one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01817101"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "A questionnaire for the assessment of organic brain deficit in elderly patients (Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-41)", 
                "measure": "Short Portable Mental Status Questionnaire (SPMSQ)", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "description": "Category verbal fluency test. Rosen W.: \"Verbal fluency in aging and dementia\". J. Clin Neuropsychol 1980;2: 135-146.", 
                "measure": "Verbal fluency test", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "description": "A cognitive test that covers a wide range of cognitive function. Battersby, W.S., Bender, M.B., Pollack, M. y Kahn, R.L. Unilateral \"spatial agnosia\" (\"inattention\") in patients with cortical lesions. Brain 1956; 79: 68-93.", 
                "measure": "Clock-drawing test", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }
        ], 
        "source": "Clinica Universidad de Navarra, Universidad de Navarra", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Clinica Universidad de Navarra, Universidad de Navarra", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}